Finally, we provide evidence that USP47 has oncogenic potential, and depletion of USP47 induces p53 by regulation of RPS2 and, therefore, inhibits cell proliferation, colony formation, and tumor progression in cancer cell lines and a mouse xenograft model in a p53-dependent manner. The gene discussed is TP53; the disease is neoplasm.